Study #2022-0712
Feasibility study: IGNITE-TX (identifying Texans at risk for hereditary cancer) intervention
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This is a community-based study requiring participant-self-enrollment, that can help to increase the rates of genetic testing among the family members of people who have been diagnosed with a hereditary cancer syndrome. The two main factors in this study are the IGNITE-TX intervention (website and navigator) and the free genetic counseling and testing. The IGNITE-TX Intervention is an innovative multi-modal intervention, with two components: a) interactive web "IGNITE-TX Hub" and b) genetic family navigators.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Gynecologic Cancer;Ovary Cancer;Pancreatic Cancer;Breast Cancer;Lynch Syndrome;Hereditary Breast and Ovarian Cancer Syndrome;Colon Cancer;Endometrial Cancer;Uterus Cancer
Study phase:
Not applicable
Physician name:
Jose Rauh-Hain
Department:
Gynecologic Oncology & Reproductive Medicine
For general questions about clinical trials:
1-833-997-2081
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.